67 results found.
Enabling Technology and Integrated Selling Strategies Drove Orthopedic Growth in the Third Quarter
The third quarter of 2019 brought some standout performances from large players like Stryker, Medtronic, NuVasive and Globus Medical. DePuy Synthes and Zimmer Biomet made incremental progress in returning to market growth. Notably, the top performing players all have well-established enabling tec...
Xtant Taps New CEO to Lead Turnaround Effort
Xtant reports 3Q19 revenue of USD $15.7MM, -8.9% vs. 3Q18.
Orthopedic Public Companies Grow 2.6% YoY in Quarter
By Mike Evers The second quarter of 2019 brought incremental improvement over the first. Year over year revenue grew 2.6% in the quarter for the public companies reported herein compared to 1.1% last quarter. The five largest orthopedic players, which control 58% of the market, showed a...
Xtant Medical to Introduce New Interbody Devices
Xtant Medical is introducing new cervical interbody devices, Intice™-C, Atrix-C Union™ and the Calix®-C PC implant.
Xtant Losses Continue in 2Q19 on Lumbar Implant Recall
Xtant reports 2Q19 revenue of USD $15.3MM, -18.5% vs. 2Q18.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Xtant Reports 1Q19 Revenue of $16.7MM, -7% vs. 1Q18
Xtant reports 1Q19 revenue of USD $16.7MM, -7% vs. 1Q18.
Xtant Reports 4Q18 Revenue of $18.3MM, -5.4% vs. 4Q17
Xtant Medical reports 4Q18 revenue of USD $18.3MM, -5.4% vs. 4Q17, with 2018 full year revenue ...
Intellirod Spine Gains FDA De Novo Clearance for LOADPRO Spine Sensing System
Intellirod Spine gained FDA de novo clearance for the LOADPRO® disposable spinal rod strain sensor, initially ...
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
Xtant Reports 3Q18 Revenue of $17.3MM, -12.7% vs. 3Q17
Xtant reports 3Q18 revenue of US $17.3MM, -12.7% vs. 3Q17.
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
Xtant Medical Expands Cervical Portfolio with First Porous Titanium Implant
Xtant Medical received FDA 510(k) clearance for its InTice™-C Porous Titanium Cervical Interbody System.
Xtant Medical Posts 1Q18 Revenue
Xtant Medical posted 1Q18 revenue of US $17.9MM, -18.8% vs. 1Q17.
curasan Enters Distribution Agreement with Implantcast
curasan entered into an exclusive agreement with Implantcast for distribution of CERASORB bone regeneration produc...
Xtant Medical Reports 3Q17 Revenue
Xtant Medical posted 3Q17 revenue of US $19.8MM, -14.3% vs. 3Q16, with YTD revenue of $63.3MM, -3.4% vs. the...
Xtant Medical and curasan Enter Distribution Agreement
Xtant Medical entered the U.S. bone graft substitute market through a distribution agreement with curasan...
Sites Medical and Integrity Implants Enter License Agreement
Sites Medical entered into an agreement to license OsteoSync™ Ti technology to Integrity Implants
Xtant Medical Receives FDA Clearance for Expanded Indications of Irix-A
Xtant Medical received FDA 510(k) clearance to market line extensions for the Irix-A standalone interbody...
Sales Results for 20 Orthopaedic Companies: A Mid-year Status Report
By Julie A. Vetalice Now that we’ve collected 1H17 results from 20 publicly-traded companies, I’d like to share some performance-based observations. With now just 4 months remaining in the year, these companies provide a helpful gauge in projecting industry growth.
Xtant Medical Posts 20.5% Orthobiologics Growth in 2Q17
Xtant Medical posted 2Q17 revenue of US $21.4MM, -0.3% vs. 2Q16, with 1H17 revenue of $43.5MM, +2....
Xtant Medical Receives Additional FDA Clearance for Calix-C Cervical Interbody Cages
Xtant Medical received FDA 510(k) clearance for additional sizes of Calix-C™ cerv...
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
Strategic orthopaedic-related 510(k)s issued in May 2017
Strategic orthopaedic-related 510(k)s issued in May 2017 include: Locking Plate System (Beijing KeYi Medical Device), Collagen Meniscus Implant XL (
Xtant Medical 1Q17 Revenue
Xtant Medical posted 1Q17 revenue of US $22.1MM, +5.3% vs. 1Q16.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group